Please use this identifier to cite or link to this item:
|Title:||Development of quality indicators to monitor radiotherapy care for men with prostate cancer: A modified Delphi method.|
|Authors:||Tsiamis, Ellie;Millar, Jeremy;Baxi, Siddhartha;Borg, Martin;De Ieso, Paolo;Elsaleh, Hany;Foroudi, Farshad;Higgs, Braden;Holt, Tanya;Martin, Jarad;Moretti, Kim;Pryor, David;Skala, Marketa;Evans, Sue|
|Affiliation:||Department of Epidemiology & Preventative Medicine, Monash University, Melbourne, Australia|
The Alfred, Radiation Oncology, Melbourne, Australia.
Genesis Cancer Care Burnbury, Australia
Adelaide Radiotherapy Centre, Australia
Northern Territory Radiation Oncology, Alan Walker Cancer Care Centre, Australia
The Australian National University, Canberra, Australia
Olivia Newton John Cancer Wellness & Research Centre, Austin Health, Heidelberg, Victoria, Australia
Department of Radiation Oncology, Royal Adelaide Hospital, Australia
Department of Radiation Oncology, Princess Alexandra Hospital, Australia
Department of Radiation Oncology, Calvary Mater Newcastle, Australia
School of Population Health, University of South Australia, Adelaide, Australia
APCRC-Q, Queensland University of Technology, Brisbane, Australia
W P Holman Clinic, Launceston, Australia
|Citation:||Radiotherapy and oncology 2018; online first: 9 May|
|Abstract:||Quality indicators (QIs) have been developed for many aspects of prostate cancer care, but are under-developed with regard to radiotherapy treatment. We aimed to develop a valid, relevant and feasible set of core QIs to measure quality of radiotherapy care in men with prostate cancer. We used a RAND-modified Delphi process to select QIs that were regarded as both important and feasible measures of quality radiotherapy care. This involved two phases: (1) a literature review to identify a list of proposed QIs; and (2) a QI selection process by an expert panel (n = 12) conducted in a series of three rounds: two online questionnaires' and one face-to-face meeting. The RAND criterion identified variation in ratings and determined the level of agreement after each round of voting. A total of 144 candidate QIs, which included measures from pre-treatment to post-treatment and survivorship care were identified. After three rounds of voting, the panel approved a comprehensive set of 17 QIs, with most assessing a process of care (n = 16, 94.1%) and the remaining assessing a health outcome. This study developed a core set of 17 QIs which will be used to report from the Prostate Cancer Outcomes Registry-Australia & New Zealand, to monitor the quality of radiotherapy care prostate cancer patients receive.|
Quality of health care
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.